SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-04-207287
Filing Date
2004-12-03
Accepted
2004-12-03 15:50:05
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ds3a.htm S-3/A 531835
2 OPINION OF ROPES AND GRAY LLP dex51.htm EX-5.1 7424
3 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 44449
4 CONSENT OF ERNST & YOUNG dex232.htm EX-23.2 1839
5 CONSENT OF ERNST & YOUNG dex233.htm EX-23.3 2361
6 STATEMENT OF ELIGIBILITY OF TRUSTEE ON FORM T-1 dex251.htm EX-25.1 35970
7 GRAPHIC g26795g21y19.jpg GRAPHIC 18234
  Complete submission text file 0001193125-04-207287.txt   644573
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-118026 | Film No.: 041183801
SIC: 2835 In Vitro & In Vivo Diagnostic Substances